Ancillare
Ancillare is the first and only Life Sciences company dedicated to Clinical Trial Ancillary Supply Chain (CTASC) for Phase I-IV clinical research. Ancillare arms Sponsors of global clinical trials with customized, end-to-end supply plans, enabling developers of new therapies to optimize their supply chains using streamlined processes, extensive global buying power, a vast depot network, and proven teams of clinical, procurement, operations, logistics and regulatory experts. Ancillare's industry-shaping model navigates the complexities of the Clinical Trial Ancillary Supply Chain to reduce both the overall cost and cycle time of clinical trials, and greatly improve operational efficiency across all levels of the value chain. Ancillare, a WBENC certified woman-owned business, has serviced the global Clinical Trial Ancillary Supply Chain (CTASC) for nearly 15 years and supported more than 1,500 clinical trials across 80,000 clinical sites over 100 countries with corporate offices in the United States and United Kingdom, and distribution hubs in Argentina, Brazil, Canada, China, Israel, Japan, South Korea, Mexico, Netherlands, Philippines, Russia, Taiwan, and Ukraine. To learn more, visit Ancillare.com.
- website: http://www.ancillare.com
- facebook: https://www.facebook.com/Ancillare/
- twitter: https://twitter.com/Ancillare1
- linkedin: http://www.linkedin.com/company/ancillare